FDA Approves ARISTADA INITIO™ for the Initiation of ARISTADA® for Schizophrenia

—  Novel Regimen Enables Physicians to Fully Dose Up to Two Months of ARISTADA Treatment on Day One  — DUBLIN, July 2, 2018 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved ARISTADA INITIO™ (aripiprazole...

from PR Newswire: //https://ift.tt/2lP1jTC